AT Bancorp cut its stake in shares of Sanofi (NYSE:SNY) by 53.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 35,739 shares of the company’s stock after selling 41,481 shares during the period. AT Bancorp’s holdings in Sanofi were worth $1,365,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Dodge & Cox raised its position in Sanofi by 3.0% in the second quarter. Dodge & Cox now owns 55,155,913 shares of the company’s stock valued at $2,308,275,000 after buying an additional 1,625,784 shares during the last quarter. Fisher Asset Management LLC raised its position in Sanofi by 0.7% in the second quarter. Fisher Asset Management LLC now owns 13,638,183 shares of the company’s stock valued at $564,894,000 after buying an additional 91,233 shares during the last quarter. Hotchkis & Wiley Capital Management LLC raised its position in Sanofi by 12.5% in the second quarter. Hotchkis & Wiley Capital Management LLC now owns 11,432,112 shares of the company’s stock valued at $478,434,000 after buying an additional 1,267,118 shares during the last quarter. Boston Partners raised its position in Sanofi by 10,203.3% in the second quarter. Boston Partners now owns 7,402,009 shares of the company’s stock valued at $309,774,000 after buying an additional 7,330,168 shares during the last quarter. Finally, Brandes Investment Partners LP raised its position in Sanofi by 1.2% in the second quarter. Brandes Investment Partners LP now owns 3,600,731 shares of the company’s stock valued at $150,691,000 after buying an additional 44,010 shares during the last quarter. Institutional investors own 9.80% of the company’s stock.

Institutional Ownership by Quarter for Sanofi (NYSE:SNY)

Shares of Sanofi (NYSE:SNY) traded up 1.79% during midday trading on Tuesday, hitting $40.44. The stock had a trading volume of 2,224,806 shares. The stock has a 50 day moving average of $39.23 and a 200-day moving average of $39.82. The company has a market cap of $104.09 billion, a P/E ratio of 23.45 and a beta of 0.97. Sanofi has a one year low of $36.81 and a one year high of $44.63.

WARNING: “AT Bancorp Has $1,365,000 Position in Sanofi (SNY)” was posted by Financial Market News and is owned by of Financial Market News. If you are accessing this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright law. The correct version of this article can be viewed at http://www.financial-market-news.com/at-bancorp-has-1365000-position-in-sanofi-sny/1209472/.

SNY has been the topic of several research reports. Berenberg Bank raised Sanofi from a “hold” rating to a “buy” rating in a research note on Thursday, September 8th. Leerink Swann reissued a “buy” rating on shares of Sanofi in a research note on Sunday, October 9th. Piper Jaffray Cos. initiated coverage on Sanofi in a research note on Friday, September 23rd. They set a “neutral” rating on the stock. BNP Paribas raised Sanofi from an “underperform” rating to a “neutral” rating in a research note on Tuesday, September 13th. Finally, TheStreet lowered Sanofi from a “buy” rating to a “hold” rating in a research note on Monday, August 22nd. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $60.50.

Sanofi Company Profile

Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.

5 Day Chart for NYSE:SNY

Want to see what other hedge funds are holding SNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sanofi (NYSE:SNY).

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.